LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

Начало・Списък с акции・Microbot Medical Inc

Microbot Medical Inc

Затворен

2.63 -4.71

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.63

Максимум

2.75

Ключови измерители
By Trading Economics
Приходи	-77K -3.6M
Служители	20
EBITDA	-79K -3.6M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+171.74% upside

Дивиденти
By Dow Jones
Следващи печалби	23.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	43M 183M
Предишно отваряне	7.34
Предишно затваряне	2.63

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

2.52 / 2.57 Подкрепа & съпротива

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.03.2026 г., 22:51 ч. UTC

Печалби

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

18.03.2026 г., 21:40 ч. UTC

Придобивния, сливания и поглъщания

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

18.03.2026 г., 20:31 ч. UTC

Печалби

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

18.03.2026 г., 23:49 ч. UTC

Пазарно говорене

Значими събития в новините

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

18.03.2026 г., 23:31 ч. UTC

Пазарно говорене

Gold Rises on Likely Technical Recovery -- Market Talk

18.03.2026 г., 22:49 ч. UTC

Пазарно говорене

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

18.03.2026 г., 22:41 ч. UTC

Пазарно говорене

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

18.03.2026 г., 22:36 ч. UTC

Печалби

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

18.03.2026 г., 22:24 ч. UTC

Печалби

AIA Group Announces New Share Buyback of $1.7B >1299.HK

18.03.2026 г., 22:23 ч. UTC

Печалби

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

18.03.2026 г., 22:23 ч. UTC

Печалби

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

18.03.2026 г., 21:58 ч. UTC

Печалби

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

18.03.2026 г., 21:55 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

18.03.2026 г., 21:55 ч. UTC

Пазарно говорене

Печалби

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

18.03.2026 г., 21:40 ч. UTC

Пазарно говорене

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

18.03.2026 г., 21:16 ч. UTC

Пазарно говорене

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

18.03.2026 г., 21:00 ч. UTC

Значими събития в новините

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

18.03.2026 г., 20:58 ч. UTC

Печалби

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

18.03.2026 г., 20:41 ч. UTC

Печалби

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18.03.2026 г., 20:29 ч. UTC

Печалби

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18.03.2026 г., 20:25 ч. UTC

Печалби

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18.03.2026 г., 20:17 ч. UTC

Печалби

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

18.03.2026 г., 20:14 ч. UTC

Пазарно говорене

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

18.03.2026 г., 20:09 ч. UTC

Печалби

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

18.03.2026 г., 20:07 ч. UTC

Печалби

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

18.03.2026 г., 20:06 ч. UTC

Печалби

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

18.03.2026 г., 20:04 ч. UTC

Печалби

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

18.03.2026 г., 20:04 ч. UTC

Печалби

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

18.03.2026 г., 20:04 ч. UTC

Печалби

Micron Technology Sees 3Q Gross Margin About 81% >MU

18.03.2026 г., 20:03 ч. UTC

Печалби

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

171.74% нагоре

12-месечна прогноза

Среден 7.5 USD 171.74%

Висок 12 USD

Нисък 5 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

Купи

Задържане

Продай

Според 3 анализатори, дали борсови рейтинги на Microbot Medical Inc през последните 3 месеца.

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.